Oncology / Hematology General
Aug 09, 2022
For a study, researchers sought to assess the shift in the frequency of unfavorable occurrences among hospitalized patients. The Medicare Patient Safety Monitoring System data from 2010 to 2019 wer...
Aug 09, 2022
For a study, researchers sought to compare high-flow nasal cannula therapy (HFNC) to continuous positive airway pressure (CPAP) to determine which was non-inferior for use as the primary noninvasive r...
Aug 09, 2022
For a study, researchers sought to ascertain if choosing an antidepressant drug was influenced by pharmacogenomic testing and whether such testing improves clinical results. A practical, randomized...
Aug 09, 2022
For a study, researchers sought to assess how fluid bolus delivery affected the incidence of severe hypotension, cardiac arrest, and mortality. Between February 1, 2019, and May 24, 2021, 1,067 cri...
Aug 09, 2022
For a study, researchers sought to evaluate the ability of omecamtiv mecarbil, a new direct myosin activator that enhances cardiac function and lowers the risk of cardiovascular mortality or the first...
Aug 09, 2022
For a study, researchers sought to examine whether using 4% albumin solution instead of Ringer acetate as the cardiopulmonary bypass prime solution and the perioperative intravenous volume replacement...
Aug 09, 2022
For a study, researchers sought to assess the association between income and life expectancy by race and ethnicity and changes in life expectancy in 2020 and 2021. California fatalities from 2015 t...
Aug 09, 2022
For a study, researchers sought to contrast laser photocoagulation with intravitreal aflibercept in newborns with retinopathy of prematurity (ROP) who require therapy. The 24-week, noninferiority, ...
Aug 09, 2022
For a study, researchers sought to evaluate the effectiveness and side effects of high-dose tranexamic acid against low-dose tranexamic acid in patients undergoing cardiopulmonary bypass. During a ...
Aug 09, 2022
For a study, researchers sought to ascertain if the financial health of dialysis facilities influences whether juvenile patients on maintenance dialysis are placed on the kidney transplant waiting lis...
Aug 09, 2022
For a study, researchers sought to find out if a recent gout flare-up caused a temporary increase in the risk of cardiovascular events. Between January 1, 1997, and December 31, 2020, electronic he...
Aug 09, 2022
For a study, researchers sought to calculate the impact of a graded sensorimotor retraining intervention (RESOLVE) on chronic low back pain patients' level of pain. Participants with chronic (>3...
Aug 02, 2022
Although TP53 mutations are a risk factor for acute myeloid leukemia (AML), large-scale integrated genomic-proteomic investigations of TP53 changes in AML patients are limited. For a study, researcher...
Aug 02, 2022
Acute lymphoblastic leukemia (ALL) is children's most frequent kind of cancer. Despite advances in treatment, T-cell acute lymphoblastic leukemia (T-ALL) recurrence is associated with chemoresistance ...
Aug 02, 2022
Immunotherapies targeting CD19 have completely changed the treatment of advanced B-cell acute lymphoblastic leukemia (B-ALL). Despite initially remarkable complete remission (CR) rates, many patients ...
Aug 02, 2022
Subsequent malignancies were well-documented consequences in cancer patients with long-term follow-up. Recently, genetically modified immune effector (IE) cells have shown efficacy in hematologic mali...
Aug 02, 2022
The most severe congenital thrombophilia, antithrombin deficiency, may be underestimated because certain pathogenic variations were not discovered by usual functional approaches. In 4 unrelated thromb...
Aug 02, 2022
The long-term follow-up of the randomized E1912 study comparing the long-term effectiveness of ibrutinib-rituximab (IR) therapy to fludarabine, cyclophosphamide, and rituximab (FCR) therapy is present...
Aug 02, 2022
Long-term prophylaxis is recommended by international recommendations in patients with von Willebrand disease (VWD) with severe and regular bleeding. Researchers evaluated the effectiveness and safety...
Aug 02, 2022
An immunological reaction to platelet factor 4 (PF4)/heparin complexes can cause a dangerous side effect called heparin-induced thrombocytopenia (HIT). In a large discovery cohort of patients divided ...
SUB SPECIALTIES
- Oncology / Hematology General
- Therapeutic Spotlight: eNSCLC
- Therapeutic Spotlight: Gynecologic Cancers
- Therapeutic Spotlight: Renal Cell Carcinoma
- Brain Cancer Oncology
- Breast Cancer Oncology
- Cervical Cancer
- Chemotherapy
- Colon Cancer
- Hematology
- Leukemia
- Lung Cancer
- Lymphoma
- Myleoma
- Ovarian Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Skin Cancer